Boeing And Airbus: A Surprisingly Close Race

Airbus and Boeing deliveries each rose 12% year over year, bringing combined aircraft output close to pre-pandemic levels. Airbus led 2026 net orders with 1,024 versus Boeing's 438, representing a $23.1 billion net-order-value advantage. Airbus deliveries exceeded its 2018 benchmark, while Boeing recovered to 88% of pre-crisis delivery levels, underscoring a broad commercial aerospace production recovery but continued relative outperformance by Airbus.

Analysis

The investable divergence is not aggregate delivery recovery but backlog quality and conversion risk. AIR.PA's stronger commercial position should support production-slot pricing, supplier bargaining power and a more credible multi-year earnings trajectory; BA remains more exposed to certification timing, rework costs, customer compensation and the risk that incremental output is absorbed by quality spending rather than operating-margin recovery. The market is likely to reward Airbus with lower execution-risk discounting even if Boeing's near-term delivery growth rate is higher off a depressed base.

Second-order beneficiaries are engine and avionics suppliers with Airbus-heavy narrowbody exposure, notably SAF.PA and GE, although both face aftermarket-versus-OEM mix trade-offs and capacity constraints. Less obvious losers are airlines dependent on Boeing delivery slots: delayed fleet replacement prolongs maintenance expense and constrains capacity growth, favoring aircraft lessors with available A320neo-family placements such as AER. Boeing's constrained supply also gives Airbus greater latitude to protect pricing rather than chase share, which matters more for 2027-28 margin expectations than the next quarter.

Over the next 1-3 months, delivery guidance, FAA production oversight, and any evidence of supplier bottlenecks will determine whether BA's recovery multiple expands or compresses. The contrarian risk is that Boeing's operational bar has become sufficiently low that modestly clean execution produces a sharper equity rerating than Airbus can generate from already-credible execution. Falsify the relative-long Airbus thesis if Boeing sustains improving monthly deliveries without renewed quality charges while Airbus cuts production targets or reports persistent engine-driven glider inventory growth; a meaningful narrowing in the BA/AIR production-certainty gap would be the key signal.

Key Decisions for Investors

• Initiate a 6-12 month relative-value position: long AIR.PA / short BA, sized dollar-neutral. Target 15-20% relative return from continued Airbus estimate resilience and Boeing execution-risk discount; reassess if Boeing delivers two consecutive quarters above guidance with no material abnormal charges.
• Add SAF.PA selectively on Airbus production confirmation rather than on order headlines. Use a 3-6 month horizon; the catalyst is higher OEM engine shipments and aftermarket visibility, while the stop condition is evidence that LEAP supply constraints are creating Airbus delivery deferrals rather than merely shifting timing.
• Maintain BA as a tactical, not structural, long only after independently verifiable production and certification milestones. A defined-risk call spread around the next earnings cycle is preferable to outright equity exposure until free-cash-flow conversion improves; upside is a recovery rerating, but downside remains renewed regulatory intervention or customer-compensation provisions.
• Watch AER as a secondary beneficiary of persistent delivery scarcity. Consider entry following evidence of lease-rate resets or improved placement spreads; avoid treating it as a pure aircraft-shortage trade if airline credit spreads widen, as funding costs and residual-value assumptions can overwhelm lease-rate gains.